{"id":"W3042832159","doi":"10.1016/j.drup.2020.100719","title":"FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy","year":2020,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Lopinavir; Hydroxychloroquine; Favipiravir; Ritonavir; Azithromycin; Clinical trial; Chloroquine; Pharmacology; Intensive care medicine; Virology; Immunology; Disease; Antibiotics; Coronavirus disease 2019 (COVID-19); Malaria; Virus; Internal medicine; Viral load; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001033164,0.001151475,0.004098468,0.0003096565,0.0003938201,0.0001435766,0.0009227297,0.0003142131,0.00009916577],"category_scores_gemma":[0.003865519,0.0007679267,0.001392739,0.0009809671,0.0006501484,0.0001275338,0.0002092142,0.001171561,0.0001084188],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007154908,"about_ca_system_score_gemma":0.003710932,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004526776,"about_ca_topic_score_gemma":0.00004867995,"domain_scores_codex":[0.9942173,0.0004044591,0.001305278,0.001795608,0.001166948,0.001110437],"domain_scores_gemma":[0.9912487,0.005906236,0.0007337342,0.00110838,0.000374077,0.0006288585],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006275537,0.0005703489,0.000006441063,0.1242232,0.004966293,0.0003665461,0.000537411,0.000002181644,0.0001776342,0.0002213237,0.08466923,0.7779838],"study_design_scores_gemma":[0.004690424,0.0002373092,8.804772e-7,0.004705299,0.001822889,0.000004180079,0.00005338473,0.00005372222,0.0001959558,0.0002983143,0.9871658,0.0007718063],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000008622872,0.9692115,0.001734234,0.02110909,0.0001949345,0.006656244,0.0004858732,0.0003598797,0.0002396875],"genre_scores_gemma":[0.00008568936,0.9752555,0.001581246,0.01542502,0.0008752171,0.002187741,0.0004609842,0.0003020416,0.003826585],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9024966,"threshold_uncertainty_score":0.9994771,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.12587865412803,"score_gpt":0.4819622007752686,"score_spread":0.3560835466472386,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}